University of Oxford

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Established: 1096-01-01

Employees: 10K

Market Cap: -

Website: http://www.ox.ac.uk

Clinical Trials

American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis

Conditions: Polyarteritis Nodosa
Churg Strauss Syndrome
Wegener's Granulomatosis
Microscopic Polyangiitis
Giant Cell Arteritis
Takayasu Arteritis

First Posted Date: 2010-02-10

Last Posted Date: 2016-08-19

Lead Sponsor: University of Oxford

Target Recruit Count: 3588

Registration Number: NCT01066208

Locations: 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸
Cedars-Sinai Medical Center, LA, Los Angeles, California, United States
🇺🇸
University of California, San Francisco, San Francisco, California, United States

and more 117 locations

The DHA (Docosahexaenoic Acid) Oxford Learning and Behaviour (DOLAB) Study

Phase 2

Completed

Conditions: Learning
Behaviour

Interventions: Dietary Supplement: DHA (docosahexaenoic acid)
Dietary Supplement: Sunflower oil capsules

First Posted Date: 2010-02-10

Last Posted Date: 2011-10-28

Lead Sponsor: University of Oxford

Target Recruit Count: 360

Registration Number: NCT01066182

Locations: 🇬🇧
Department of Social Policy and Social Work, Oxford, Oxfordshire, United Kingdom

Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy

Phase 3

Completed

Conditions: Malaria

Interventions: Drug: arthemeter-lumefantrin
Drug: dihydroartemisinin-piperaquine
Drug: Artesunate-mefloquine

First Posted Date: 2010-01-22

Last Posted Date: 2022-03-25

Lead Sponsor: University of Oxford

Target Recruit Count: 511

Registration Number: NCT01054248

Locations: 🇹🇭
Shoklo Malaria Research Unit, Mae Sot, Tak, Thailand

Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring

Completed

Conditions: Metastatic Colorectal Cancer
Metastatic Breast Cancer

First Posted Date: 2010-01-21

Last Posted Date: 2012-07-25

Lead Sponsor: University of Oxford

Target Recruit Count: 26

Registration Number: NCT01053104

Locations: 🇬🇧
Oxford Cancer Centre, Churchill Hospital, Oxford, United Kingdom

Metformin Treatment Before in Vitro Fertilization (IVF) in Women With Ultrasound Evidence of Polycystic Ovaries

Not Applicable

Completed

Conditions: Polycystic Ovary Syndrome

Interventions: Drug: Placebo
Drug: Metformin

First Posted Date: 2010-01-11

Last Posted Date: 2010-01-11

Lead Sponsor: University of Oxford

Target Recruit Count: 134

Registration Number: NCT01046032

Locations: 🇬🇧
IVF Hammersmith, London, United Kingdom
🇬🇧
Nuture IVF Unit, Nottingham, United Kingdom
🇬🇧
Oxford Fertility Unit, Oxford, United Kingdom

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

Phase 1

Terminated

Conditions: HIV-1

Interventions: Biological: MVA.HIVconsv high dose
Other: Placebo high dose
Biological: MVA.HIVconsv low dose
Other: Placebo low dose

First Posted Date: 2009-12-03

Last Posted Date: 2016-06-08

Lead Sponsor: University of Oxford

Target Recruit Count: 19

Registration Number: NCT01024842

Locations: 🇬🇧
Oxford Genitourinary Medicine, Oxford, Oxon, United Kingdom
🇬🇧
Weatherall Institute of Molecular Medicine, Oxford, Oxons, United Kingdom

A Study of the Safety and Effectiveness of Two New Malaria Vaccines

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: AdCh63-MSP1 (lower dose) vaccine and MVA-MSP1 vaccine
Biological: AdCh63-MSP1 vaccine (higher dose) and MVA-MSP1 vaccine followed by challenge

First Posted Date: 2009-10-28

Last Posted Date: 2011-03-28

Lead Sponsor: University of Oxford

Target Recruit Count: 16

Registration Number: NCT01003314

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom

Questscope Non-Formal Education Impact Study

Phase 2

Completed

Conditions: Education
Empowerment
Self-efficacy

Interventions: Behavioral: Questscope Non-Formal Education

First Posted Date: 2009-10-26

Last Posted Date: 2011-08-04

Lead Sponsor: University of Oxford

Target Recruit Count: 200

Registration Number: NCT01001286

Locations: 🇯🇴
Al Mutasm School, Amman, Jordan
🇯🇴
Al Zubaidieh School, Amman, Jordan
🇯🇴
Ali Reda Al Rekabi School, Amman, Jordan

and more 3 locations

A Study to Assess the Safety and Efficacy of a New Influenza Candidate Vaccine MVA-NP+M1 In Healthy Adults

Phase 2

Completed

Conditions: Influenza

Interventions: Biological: MVA-NP+M1

First Posted Date: 2009-10-09

Last Posted Date: 2011-08-11

Lead Sponsor: University of Oxford

Target Recruit Count: 27

Registration Number: NCT00993083

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Churchill Hospital, Oxford, Oxfordshire, United Kingdom
🇬🇧
Wellcome Trust Clinical Research Facility, University of Southampton, Southampton, Hampshire, United Kingdom

A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum Malaria

Phase 1

Completed

Conditions: Malaria

Interventions: Biological: AMA1-C1/Alhydrogel® + CPG 7909

First Posted Date: 2009-09-25

Last Posted Date: 2015-05-28

Lead Sponsor: University of Oxford

Target Recruit Count: 8

Registration Number: NCT00984763

Locations: 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, Headington, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy